Chiara Vismara
About
Chiara Vismara is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry.
According to data from OpenAlex, Chiara Vismara has authored 31 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 10 papers in Epidemiology and 4 papers in Clinical Biochemistry. Recurrent topics in Chiara Vismara's work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Chiara Vismara is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Chiara Vismara collaborates with scholars based in Italy, United States and Spain. Chiara Vismara's co-authors include Carlo Federico Perno, Fausto Baldanti, Valeria Cento, Daniela Campisi, Elena Percivalle, Alessandra Bielli, Massimo Puoti, Claudia Zierold, Fabrizio Bonelli and L. Pallavicini and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Clinical Microbiology.
In The Last Decade
Chiara Vismara
26 papers receiving 377 citations
Peers
Chiara Vismara
Hitoshi Kawasuji Japan
Tracy McMillen United States
Wan Beom Park South Korea
Josep Pareja Spain
Reed Magleby United States
Sonia N. Rao United States
Scott Matushek United States
Ali Toloue Ostadgavahi Canada
Vera Tešić United States
Shiraz Gefen-Halevi Israel
Citations per year, relative to Chiara Vismara Chiara Vismara (= 1×)
peers
Hitoshi Kawasuji
Countries citing papers authored by Chiara Vismara
Since
Specialization
Citations
This map shows the geographic impact of Chiara Vismara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Vismara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Vismara more than expected).
Fields of papers citing papers by Chiara Vismara
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Chiara Vismara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Vismara. The network helps show where Chiara Vismara may publish in the future.
Co-authorship network of co-authors of Chiara Vismara
This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Vismara. A scholar is included among the top collaborators of Chiara Vismara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Vismara. Chiara Vismara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Travi, Giovanna, Alessandra Bielli, Elisa Matarazzo, et al.. (2025). Outbreak of Vancomycin-Resistant Enterococcus in a NICU: Insights into Molecular Detection and Infection Control. Microorganisms. 13(4). 822–822.
2.
Stefani, Stefania, Felice Arena, Luigi Principe, et al.. (2025). Evaluating Antimicrobial Susceptibility Testing Methods for Cefiderocol: A Review and Expert Opinion on Current Practices and Future Directions. Preprints.org.
3.
Bartolini, L., Andrea Berlingeri, Barbara Camilloni, et al.. (2025). Evaluation of a digital remote extraction analysis and monitoring tool for key performance indicators (KPIs) in the blood culture process. European Journal of Clinical Microbiology & Infectious Diseases. 44(11). 2761–2770.
4.
Törümküney, Didem, Rafael Cantón, Cristina Pitart, et al.. (2025). Results from the Survey of Antibiotic Resistance (SOAR) 2018–21 in Italy and Spain: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. Journal of Antimicrobial Chemotherapy. 80(Supplement_3). iii2–iii18.
5.
Ghodousi, Arash, et al.. (2024). Evaluating the efficacy of whole genome sequencing in predicting susceptibility profiles for first-line antituberculosis drugs. Clinical Microbiology and Infection. 31(1). 121.e1–121.e5.
6.
Rimoldi, Sara Giordana, Alberto Rizzo, Cristina Pagani, et al.. (2024). Evaluation of 16S-Based Metagenomic NGS as Diagnostic Tool in Different Types of Culture-Negative Infections. Pathogens. 13(9). 743–743.
7.
Travi, Giovanna, Marco Merli, Elisa Matarazzo, et al.. (2024). Cefiderocol-Based Regimen for Acinetobacter NDM-1 Outbreak. Antibiotics. 13(8). 770–770.
8.
Piazza, Aurora, Vittoria Mattioni Marchetti, Alessandra Bielli, et al.. (2024). A novel KPC-166 in ceftazidime/avibactam resistant ST307 Klebsiella pneumoniae causing an outbreak in intensive care COVID Unit, Italy. Journal of Microbiology Immunology and Infection. 57(3). 457–469.
9.
Rossotti, Roberto, Federico D’Amico, Alice Nava, et al.. (2024). Durability of doravirine with dolutegravir dual regimen compared with other dolutegravir‐based dual combinations. HIV Medicine. 25(6). 675–683.
10.
Rizzetto, Francesco, Stefano Carrazza, Silvia Nerini Molteni, et al.. (2023). Artificial intelligence for differentiating COVID-19 from other viral pneumonias on CT: comparative analysis of different models based on quantitative and radiomic approaches. European Radiology Experimental. 7(1).
11.
Scutari, Rossana, Silvia Renica, Valeria Cento, et al.. (2023). Quantitative SARS-CoV-2 subgenomic RNA as a surrogate marker for viral infectivity: Comparison between culture isolation and direct sgRNA quantification. PLoS ONE. 18(9). e0291120–e0291120.
12.
Crocchiolo, Roberto, Anna Maria Gallina, Arianna Pani, et al.. (2022). Polymorphism of the HLA system and weak antibody response to BNT162b2 mRNA vaccine. HLA. 99(3). 183–191.
13.
Rossotti, Roberto, Alice Nava, Chiara Baiguera, et al.. (2022). High prevalence of anal papillomavirus infection in men who have sex with men PrEP users. Sexually Transmitted Infections. sextrans–2022.
14.
Crocchiolo, Roberto, Mariateresa Pugliano, Laura Bellio, et al.. (2021). SARS-COV-2 screening in allogeneic hematopoietic stem cell donors: Implications for the evaluation process and eligibility. Hematology Transfusion and Cell Therapy. 44(1). 13–16.
15.
Cento, Valeria, Silvia Renica, Elisa Matarazzo, et al.. (2021). Frontline Screening for SARS-CoV-2 Infection at Emergency Department Admission by Third Generation Rapid Antigen Test: Can We Spare RT-qPCR?. Viruses. 13(5). 818–818.
16.
Länger, Thomas, Riccardo Giudici, Gabriele Bassi, et al.. (2020). Development of machine learning models to predict RT-PCR results for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with influenza-like symptoms using only basic clinical data. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 28(1). 113–113.
17.
Cento, Valeria, Alice Nava, Luna Colagrossi, et al.. (2020). Prolongation of incubation time improves clinical diagnosis of Mycobacterium xenopi infection and allows susceptibility testing of mycobacterial strains against multiple antibiotics. Journal of Global Antimicrobial Resistance. 22. 533–537.
18.
Gatti, Milo, Anna Rossi, Osvaldo Chiara, et al.. (2019). Intensive multidisciplinary management in critical care patients affected by severe necrotizing soft tissue infections: a cooperative method to improve the efficacy of treatment. European Journal of Clinical Microbiology & Infectious Diseases. 38(6). 1153–1162.
19.
Auxilia, F., Marino Faccini, Sabrina Senatore, et al.. (2016). Legionnaires' disease contracted from patient workplace: First report of a severe case of coinfection with varicella-zoster virus. American Journal of Infection Control. 44(10). 1164–1165.
20.
Faron, Matthew L., Blake W. Buchan, Chiara Vismara, et al.. (2015). Automated Scoring of Chromogenic Media for Detection of Methicillin-Resistant Staphylococcus aureus by Use of WASPLab Image Analysis Software. Journal of Clinical Microbiology. 54(3). 620–624.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Hitoshi Kawasuji Breakdown of academic impact, for papers by Tracy McMillen Breakdown of academic impact, for papers by Wan Beom Park Breakdown of academic impact, for papers by Josep Pareja Breakdown of academic impact, for papers by Reed Magleby Breakdown of academic impact, for papers by Sonia N. Rao Breakdown of academic impact, for papers by Scott Matushek Breakdown of academic impact, for papers by Ali Toloue Ostadgavahi Breakdown of academic impact, for papers by Vera Tešić Breakdown of academic impact, for papers by Shiraz Gefen-Halevi